About Us
At Magno Medical Research Group, we believe that advancing medicine begins with caring for people. Our site was founded with a clear purpose: to bridge the gap between patients who need access to innovative treatments and the Sponsors and CROs developing tomorrow’s therapies.
We are more than just a clinical research facility—we are a dedicated team of physicians, nurses, and research professionals who share a passion for discovery, compassion for our patients, and commitment to the highest standards of care and compliance.
What We Do
Magno Medical Research Group specializes in conducting Phase II–IV trials across multiple therapeutic areas, including neurology, psychiatry, internal medicine, and metabolic diseases. Our modern facility includes exam rooms, a secure investigational pharmacy, and on-site laboratory capabilities, while our partnerships with external providers give us access to advanced imaging, infusion services, and specialty procedures.
Our Promise
For patients, we provide access to cutting-edge research, study-related care at no cost, and a supportive team that guides them every step of the way. For Sponsors and CROs, we deliver efficient study start-up, reliable data, and a strong track record of quality and compliance.
At Magno Medical Research Group, we are building more than studies—we are building trust, hope, and a healthier tomorrow.
Our Commitment to Participants
Joining a clinical trial can feel overwhelming, which is why we prioritize clarity, compassion, and care. All study-related visits, procedures, and assessments are provided at no cost, and many trials offer compensation for time and travel. Participants are always fully informed, supported by bilingual staff (English and Spanish), and treated with the highest standards of privacy and respect.
Our Commitment to Sponsors & CROs
We understand the importance of precision and efficiency in clinical research. Our strengths include:
-
Rapid feasibility and contract turnaround.
-
Proven recruitment strategies with access to a diverse, pre-screened patient database.
-
SOP-driven workflows ensuring ICH-GCP, FDA, and HIPAA compliance.
-
Experienced investigators with a history of successful Phase II–IV trial execution.
-
Seamless collaboration with central IRBs, vendors, and monitoring teams.
Our Investigators
Cecilio Douglas Campbell, MD
Investigator - Internal Medicine
Dr. Campbell is a board-certified Internal Medicine specialist and experienced Principal Investigator with over 30 years of medical practice and more than a decade dedicated to clinical research. He has led and contributed to numerous Phase II–IV clinical trials in therapeutic areas including Alzheimer’s disease, Major Depressive Disorder, Parkinson’s disease, Schizophrenia, NASH, Asthma, Migraine, Opioid Dependence, and COVID-19.
His leadership at Magno Medical Research Group reflects a strong commitment to advancing medicine through innovation, patient safety, and high-quality research
Richard Douyon, MD
Investigator - Psychiatrist
Dr. Douyon is a board-certified psychiatrist and Principal Investigator with over three decades of clinical, academic, and research experience. He has served as faculty at the University of Miami School of Medicine and held leadership roles at the Miami VA Medical Center, directing psychiatric programs and conducting numerous clinical trials in schizophrenia, bipolar disorder, depression, Parkinson’s disease, substance dependence, and HIV-related neuropsychiatric disorders. Fluent in English, Spanish, and Creole, Dr. Douyon brings extensive expertise and a strong commitment to advancing mental health research and patient care.
Edgart Morfa, NP
Investigator
Mr. Morfa is an Advanced Registered Nurse Practitioner and Certified Clinical Research Coordinator with extensive experience in clinical trial operations. At Magno Medical Research Group, he serves as a Sub-Investigator and Rater, conducting physical examinations, performing assessments, administering investigational products, and overseeing rating scales across multiple therapeutic areas. With advanced training in nursing, intensive care, and psychological development, he brings both clinical expertise and research precision to support high-quality study execution.